cbdMD regains NYSE American compliance; BC indicator removed Dec 8, 2025

cbdMD, Inc.

Received NYSE American letter Dec 5, 2025 confirming compliance with Sections 1003(a)(i) and (ii).
Previously identified deficiencies resolved; BC indicator removed effective Dec 8, 2025.
CEO credits May Series A Preferred share conversion and September capital raise as key to compliance.
Company remains subject to continued listing monitoring going forward.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.